CN103100075B - Medicament for treating eczema - Google Patents
Medicament for treating eczema Download PDFInfo
- Publication number
- CN103100075B CN103100075B CN201310063816.4A CN201310063816A CN103100075B CN 103100075 B CN103100075 B CN 103100075B CN 201310063816 A CN201310063816 A CN 201310063816A CN 103100075 B CN103100075 B CN 103100075B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating eczema. The medicament is prepared from the following substances in parts by weight: 5-10 parts of figwort root, 10-20 parts of dried ginger, 20-30 parts of dogwood fruit, 10-20 parts of balloonflower root, 15-25 parts of dahurian angelica root, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of dutchmanspipe vine, 10-20 parts of ledebouriella root, 15-30 parts of herba ephedrae, 20-30 parts of belleric terminalia fruit, 1-20 parts of morinda root, 1-20 parts of barbat skullcap, 10-25 parts of cogongrass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of natural indigo, 10-20 parts of giant knotweed, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of senna leaf, 5-15 parts of root or all-grass of aleppo avens, 1-20 parts of radix rhapontici, 15-25 parts of dahurian rhododendron leaf, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of mulberry bark, 20-30 parts of lindley eupatorium, 1-20 parts of blackberrylily rhizome and 10-25 parts of rhododendron molle. According to the medicament for treating eczema, disclosed by the invention, all ingredients are natural materials, the safety performance is better, and the curative effect is clear, so that the medicament is suitable for being clinically popularized in a large scale.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of eczema.
Background technology
Eczema (eczema) is that the inflammatory skin of a kind of common epidermis being caused by multiple internal and external factor and high dermis is sick, it is generally acknowledged with allergy and has certain relation.Its clinical manifestation has the features such as symmetry, exudative, itching skin disease, pleomorphism and recurrent.Eczema is a kind of dermatosis of easy recurrence, treatment needs recurrent medicine dedicated, as the medicine that contains the clean skin composition of health, be also a kind of allergic inflammation dermatoses with erythra multiformity, it is feature that symmetrical, violent pruritus shows effect, easily develops into chronic repeatedly.Can betide any position of any age, in any season, but recur or aggravate the winter of being everlasting, have the tendency of oozing out, the chronic course of disease, easily outbreak repeatedly.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of eczema.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of eczema, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Rhizoma Belamcandae 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of eczema of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Scutellariae Barbataes, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 17 parts of Rhizoma Polygoni Cuspidati, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppicies, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Rhizoma Belamcandae and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or ointment.
Whole compositions of the medicament for the treatment of eczema of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment ointment of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of the Radixs Angelicae Dahuricae, 13 grams of Flos Inulaes, 28 grams of Semen Vaccariae, 11 grams of Herba Aristolochiaes, 17 grams of Radix Saposhnikoviaes, 24 grams, Herba Ephedrae, 27 grams of Fructus Terminaliae Billericaees, 18 grams of Radix Morindae Officinaliss, 17 grams of Herba Scutellariae Barbataes, 23 grams of Rhizoma Imperataes, 21 grams of Fructus Xanthii, 16 grams of Fructus Phyllanthis, 16 grams of Indigo Naturaliss, 17 grams of Rhizoma Polygoni Cuspidati, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppicies, 13 grams of Radix Rhapontici, 23 grams of Folium Rhododendri Daurici, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Cortex Mori, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Rhizoma Belamcandae and Flos Rhododendri Mollis, micronization is pulverized, cross 100 mesh sieves, mix homogeneously.To adding 350 grams, 200 grams of liquid paraffin and vaseline in the above-mentioned powder mixing, be stirred to and be even paste, obtain.
Experimental example
30 examples all meet the diagnostic criteria of " clinical dermatology " eczema (Zhao debates. clinical dermatology [M]. the 3rd edition. Nanjing: Jiangsu science tech publishing house, 2001.605.).Man's 19 examples, female's 11 examples; Age 22-61 year, average 42.3 years old; The course of disease 3 months-2 years, average 0.6 year; Forethiga eczema 6 examples, the back of the hand portion eczema 4 examples, buttocks eczema person 1 example, huckle eczema person 7 examples, legs eczema person 9 examples, dorsal portion eczema 3 examples.Show as skin lesion and be pleomorphism, be apt to occur in face, hands, foot, shank, visible red mottle or dark red mottle, pimple, vesicle, ooze out, rotten to the corn etc., visible pustule, pus crusts during secondary infection, acute pruritus, accompanies vexed, thirsty, constipation, red tongue yellow fur, slippery and rapid pulse.
Use the ointment of preparation in embodiment 1 to treat for above-mentioned patient, to be evenly applied to affected part, be as the criterion, one day twice, each every place evenly smeared 20 grams, take seven days as a course for the treatment of.
Criterion of therapeutical effect
Recovery from illness: erythra all disappears, and only leaves over pigmentation, pruritus transference cure, follows up a case by regular visits to not recurrence in 1 year.Effective: erythra obviously disappears or major part disappears, and pruritus obviously alleviates, even in 1 year have recurrence, but symptom is slight, and skin lesion is front minimizing.Effective: erythra partly disappears, symptom takes a turn for the better, and has slight pruritus.Invalid: erythra is without disappearing or symptom increases the weight of.
30 routine patients erythra after treating 1 course for the treatment of all disappears, and only leaves over pigmentation, pruritus transference cure.Follow up a case by regular visits to not recurrence in 1 year.Therefore all meet recovery from illness standard.
Claims (2)
1. a medicament for the treatment of eczema, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Rhizoma Belamcandae 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of eczema according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Scutellariae Barbataes, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 17 parts of Rhizoma Polygoni Cuspidati, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppicies, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Rhizoma Belamcandae and Flos Rhododendri Mollis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310063816.4A CN103100075B (en) | 2013-03-01 | 2013-03-01 | Medicament for treating eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310063816.4A CN103100075B (en) | 2013-03-01 | 2013-03-01 | Medicament for treating eczema |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103100075A CN103100075A (en) | 2013-05-15 |
CN103100075B true CN103100075B (en) | 2014-01-22 |
Family
ID=48308487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310063816.4A Expired - Fee Related CN103100075B (en) | 2013-03-01 | 2013-03-01 | Medicament for treating eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103100075B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417720A (en) * | 2013-08-05 | 2013-12-04 | 谢明臣 | Traditional Chinese medicine composition for treating infant eczema |
CN103417721A (en) * | 2013-08-05 | 2013-12-04 | 谢明臣 | Medicine for treating eczema and preparation method thereof |
CN103393835A (en) * | 2013-08-05 | 2013-11-20 | 谢明臣 | Traditional Chinese medicine composition for treatment of xerotic eczema |
CN103720939A (en) * | 2013-12-16 | 2014-04-16 | 张圣坤 | Lotion for treating eczematous dermatitis |
CN106421721A (en) * | 2016-11-29 | 2017-02-22 | 浙江施强制药有限公司 | Traditional Chinese medicinal composition for treating eczema and preparation method of traditional Chinese medicinal composition |
-
2013
- 2013-03-01 CN CN201310063816.4A patent/CN103100075B/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
何英滔,等.中药外治湿疹研究概况.《湖南中医杂志》.2012,第28卷(第2期),第135-136页. * |
陈平,等.外用中药治疗慢性湿疹研究进展.《中华中医药学刊》.2012,第30卷(第3期),第523-526页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103100075A (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103100075B (en) | Medicament for treating eczema | |
CN101554424B (en) | Traditional Chinese medicine for treating skin diseases and preparation method thereof | |
CN103341145A (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
CN104208245A (en) | Traditional Chinese medicine medicated bath for tinea of feet and hands and preparation method thereof | |
CN104474028B (en) | Ointment for the treatment of skin pruritus and preparation method thereof | |
CN102266422A (en) | Chinese medicinal preparation for treating slight and severe chilblains and production method thereof | |
CN102293931B (en) | Traditional Chinese medicinal composition, clinical preparation and preparation methods thereof | |
CN103142959A (en) | Medicament for treating urticaria | |
CN108078903B (en) | Plant acne-removing composition and preparation method thereof | |
CN101843861B (en) | Chinese medicinal composition for treating tonsillitis | |
CN102670877B (en) | Medicament for treating eczema | |
CN103989850A (en) | Chinese herbal medicine extract composition for preventing diaper dermatitis and application method of composition | |
CN101537148A (en) | External application drug for curing eczema and preparation method thereof | |
CN102327460B (en) | Medicament for treating eczema | |
CN102512544A (en) | Traditional Chinese medicinal preparation for treating athlete's foot (barbier) and vaginitis and preparation method of same | |
CN103100076B (en) | Medicament for treating eczema | |
CN102935218B (en) | Traditional Chinese medicine composition for treating decubitus in clinical care | |
CN101612203B (en) | Traditional Chinese medicine composition used for treating pointed condyloma and application thereof | |
CN102579789B (en) | Medicine for treating eczema | |
CN109999111A (en) | A kind of pharmaceutical composition and preparation method thereof for treating acne | |
CN113663049B (en) | Li nationality medicine postpartum medicated bath effervescent granules and preparation method thereof | |
CN103071046B (en) | Medicine paste for treating high myopia macular hemorrhage | |
CN103142960B (en) | Medicament for treating skin diseases | |
CN101708294B (en) | Medicinal composition for treating dermatosis chronic disease and preparation method thereof | |
CN102058755A (en) | Pharmaceutical composition for treatment of psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140122 Termination date: 20150301 |
|
EXPY | Termination of patent right or utility model |